ILUVIEN implants diabetic macular edema treamtent in dubai uae

ILUVIEN delivers proven efficacy

► ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg is an implant injected into the eye (vitreous) and is used for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a significant increase in eye pressure.
► Based on the results of 2 clinical studies, ILUVIEN was proven to be safe and effective in the treatment of this condition as demonstrated for 24 months.
► A single implant delivers the steroid for 36 months.
► During the 3-year clinical trial, 75% of the people treated with ILUVIEN only had 1 ILUVIEN implant.

See how ILUVIEN works

ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg is a tiny implant that releases a low dose of a steroid called fluocinolone acetonide (FAc) to the retina. This helps treat the inflammation and edema associated with diabetic macular edema (DME).

In-office procedure

The ILUVIEN implant is injected into the eye with a custom inserter with a tiny needle, so there are no stitches needed.

The ILUVIEN implant begins to release low levels of steroid therapy to the retina in continuous, predictable amounts for 36 months.

ILUVIEN implants diabetic macular edema treamtent in dubai uae

In-office procedure

A single ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg implant is administered by a retina specialist during an in-office procedure. No surgery or hospital stay is typically required. And there are no stitches.

The injection procedure

Prior to the procedure, your eye is numbed. The ILUVIEN implant is then injected with a specialized inserter that has a tiny needle. As the implant is being injected, you may feel some pressure.

Discomfort afterwards

People who get injections in the eye can sometimes feel slight pressure in the eye afterwards. Intravitreal injections, including those with ILUVIEN, have been associated with serious eye infection (endophthalmitis), eye inflammation, increased eye pressure, and retinal detachments. Patients should be monitored following the intravitreal injection.

Tell your doctor

Tell your doctor immediately if the eye becomes red, sensitive to light, painful.